[1] |
WHO. A roadmap for implementation: accelerating work to overcome the global impact of neglected tropical diseases[EB/OL]. Geneva: World Health Organization, 2012. (2012-02-11)[2020-06-15]. https://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.
|
[2] |
Zhang LJ, Xu ZM, Yang F, et al. Endemic status of schistosomiasis in People’s Republic of China in 2020[J]. Chin J Schisto Control, 2021, 33(3):225-233. (in Chinese)
|
|
( 张利娟, 徐志敏, 杨帆, 等. 2020年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2021, 33(3):225-233.)
|
[3] |
Bureau of Disease Control of Health Ministry.PR China. Handbook of schistosomiasis control[M]. 3rd ed. Shanghai: Science and Technology Publishing House of Shanghai, 2000: 98. (in Chinese)
|
|
(中华人民共和国卫生部疾病控制司. 血吸虫病防治手册[M]. 3版. 上海: 上海科学技术出版社, 2000: 98.)
|
[4] |
Hu F, Li YF, Yuan M, et al. Development and application of information system for epidemiological investigation on parasitic diseases[J]. Chin J Parasitol Parasit Dis, 2014, 32(5):398-401. (in Chinese)
|
|
( 胡飞, 李宜锋, 袁敏, 等. 寄生虫病现场流行病学调查信息系统的研制及其应用效果[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5):398-401.)
|
[5] |
King CH. It’s time to dispel the myth of “asymptomatic” schistosomiasis[J]. PLoS Negl Trop Dis, 2015, 9(2):e0003504.
doi: 10.1371/journal.pntd.0003504
|
[6] |
Bärenbold O, Raso G, Coulibaly JT, et al. Estimating sensitivity of the Kato-Katz technique for the diagnosis of Schistosoma mansoni and hookworm in relation to infection intensity[J]. PLoS Negl Trop Dis, 2017, 11(10):e0005953.
doi: 10.1371/journal.pntd.0005953
|
[7] |
Deng Y, Qiu C, Ding H, et al. The ratio of the seroprevalence to the egg-positive prevalence of Schistosoma japonicum in China: a meta-analysis[J]. BMC Infect Dis, 2018, 18(1):404.
doi: 10.1186/s12879-018-3320-5
pmid: 30111280
|
[8] |
Gazzinelli-Guimaraes PH, Dhanani N, King CH, et al. Accuracy of the WHO praziquantel dose pole for large-scale community treatment of urogenital schistosomiasis in northern Mozambique: is it time for an update?[J]. PLoS Negl Trop Dis, 2018, 12(11):e0006957.
doi: 10.1371/journal.pntd.0006957
|
[9] |
Olveda RM, Tallo V, Olveda DU, et al. National survey data for zoonotic schistosomiasis in the Philippines grossly underestimates the true burden of disease within endemic zones: implications for future control[J]. Int J Infect Dis, 2016, 45:13-17.
|
[10] |
Ross AG, Olveda RM, Li YS. An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration[J]. Lancet, 2015, 385(9983):2220-2221.
doi: 10.1016/S0140-6736(14)61417-3
|
[11] |
Ge J, Hu F, Zhang LJ, et al. Evaluation and analysis of schistosomiasis control in model demonstration and expansion areas with infection sources control strategy implemented in Jiangxi Province[J]. Chin J Parasitol Parasit Dis, 2019, 37(6):625-631. (in Chinese)
|
|
( 葛军, 胡飞, 张利娟, 等. 江西省传染源控制策略示范区和推广区建设项目血防效果评估与分析[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(6):625-631.)
|
[12] |
Chen XY, Wang LY, Cai JM, et al. Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992—2001)[J]. Bull World Health Organ, 2005, 83(1):43-48.
|
[13] |
Knopp S, Becker SL, Ingram KJ, et al. Diagnosis and treatment of schistosomiasis in children in the era of intensified control[J]. Expert Rev Anti Infect Ther, 2013, 11(11):1237-1258.
doi: 10.1586/14787210.2013.844066
|
[14] |
Webster JP, Molyneux DH, Hotez PJ, et al. The contribution of mass drug administration to global health: past, present and future[J]. Philos Trans R Soc Lond B Biol Sci, 2014, 369(1645):20130434.
doi: 10.1098/rstb.2013.0434
|
[15] |
Kloetzel K. Reinfection after treatment of schistosomiasis: environment or “predisposition” ?[J]. Rev Inst Med Trop Sao Paulo, 1990, 32(2):138-146.
doi: 10.1590/S0036-46651990000200012
|
[16] |
Wu W, Huang YX. Application of praziquantel in schistosomiasis japonica control strategies in China[J]. Parasitol Res, 2013, 112(3):909-915.
doi: 10.1007/s00436-013-3303-9
|
[17] |
Lin DD, Zhang SJ, Hu GH, et al. Study on pattern of new infection and reinfection after implementing the strategy of chemotherapy combined with health education for schistosomiasis control in Poyang lake region[J]. Chin J Parasit Dis Control, 1998, 11(1):43-45. (in Chinese)
|
|
( 林丹丹, 张绍基, 胡广汉, 等. 鄱阳湖区实施化疗结合健教策略后居民血吸虫病新感染和再感染规律的研究[J]. 中国寄生虫病防治杂志, 1998, 11(1):43-45.)
|
[18] |
Fan YB, Fu RL. Progress of research on acquired immunity and reinfection of schistosome in humans[J]. Chin J Schisto Control, 2007, 19(6):479-481. (in Chinese)
|
|
( 范义兵, 傅仁龙. 人体血吸虫再感染与获得性免疫研究进展[J]. 中国血吸虫病防治杂志, 2007, 19(6):479-481.)
|
[19] |
Tingley GA, Butterworth AE, Anderson RM, et al. Predisposition of humans to infection with Schistosoma mansoni: evidence from the reinfection of individuals following chemotherapy[J]. Trans Royal Soc Trop Med Hyg, 1988, 82(3):448-452.
doi: 10.1016/0035-9203(88)90159-9
|
[20] |
Guo XY, He N, Jiang QW. Risk factors associated with reinfection of Schistosoma japonicum[J]. Chin J Epidemiol, 2004, 25(8):691-694. (in Chinese)
|
|
( 郭肖岩, 何纳, 姜庆五. 日本血吸虫再感染危险因素的探讨[J]. 中华流行病学杂志, 2004, 25(8):691-694)
|
[21] |
Jiang PY, Pan WQ. Advances in liver fibrosis and pathogenesis of schistosomiasis[J]. Chin Trop Med, 2018, 18(8):847-852. (in Chinese)
|
|
( 姜鹏月, 潘卫庆. 血吸虫病肝纤维化及其致病机制研究进展[J]. 中国热带医学, 2018, 18(8):847-852.)
|
[22] |
Wilson MS, Mentink-Kane MM, Pesce JT, et al. Immunopathology of schistosomiasis[J]. Immunol Cell Biol, 2007, 85(2):148-154.
pmid: 17160074
|
[23] |
Zhou S, Jin X, Chen X, et al. Heat shock protein 60 in eggs specifically induces tregs and reduces liver immunopathology in mice with schistosomiasis japonica[J]. PLoS One, 2015, 10(9):e0139133.
doi: 10.1371/journal.pone.0139133
|
[24] |
Ross AG, Olveda RM, Chy D, et al. Can mass drug administration lead to the sustainable control of schistosomiasis?[J]. J Infect Dis, 2015, 211(2):283-289.
doi: 10.1093/infdis/jiu416
|
[25] |
Ross AG, McManus DP, Farrar J, et al. Neuro schistosomiasis[J]. J Neurol, 2012, 259(1):22-32.
doi: 10.1007/s00415-011-6133-7
|
[26] |
Olveda RM, Daniel BL, Ramirez BD, et al. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity[J]. J Infect Dis, 1996, 174(1):163-172.
pmid: 8655987
|
[27] |
Olds GR, Olveda R, Wu G, et al. Immunity and morbidity in schistosomiasis japonicum infection[J]. Am J Trop Med Hyg, 1996, 55(5 suppl):121-126.
pmid: 8940965
|
[28] |
Cook GC. History of parasitology[M]// Principles and practise of clinical parasitology. Chichester, UK: John Wiley & Sons, Ltd, 2002: 1-20.
|
[29] |
Lin D, Zhang S, Murakami H, et al. Impact mass chemotherapy with praziquantel on schistosomiasis control in Fanhu Village, People’s Republic of China[J]. Southeast Asian J Trop Med Pub Health, 1997, 28(2):274-279.
|
[30] |
Chen C, Bai RP, He X, et al. Investigation on the role of praziquantel against Schistosoma japonicum induced liver fibrosis and expression change of host miRNA[J]. Int J Med Parasit Dis, 2015, 42(1):1-5, 13. (in Chinese)
|
|
( 陈超, 白瑞璞, 何兴, 等. 吡喹酮对日本血吸虫病肝纤维化的治疗作用及宿主miRNA表达变化[J]. 国际医学寄生虫病杂志, 2015, 42(1):1-5, 13.)
|